Vir Biotechnology Appoints Suzanne Topalian to Its Board of Directors
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Volkswagen’s Q3 Operating Loss Widens
Volkswagen reported a third-quarter operating loss, compared with a loss a year earlier. Revenue fell more than expected. The quarterly loss was its worst since the 2015 diesel sca
M impact | EQUITY | Oct 29, 2026, 09:20 AM UTC
Mi Technovation Reports Third-Quarter 2026 Earnings
Revenue was MYR 256.038 million and pretax profit was MYR 82.327 million for the quarter ended September 30, 2026. The supplied table compares these with MYR 197.059 million and MY
M impact | EQUITY | Oct 29, 2026, 09:20 AM UTC
Enento Group launches share buyback of up to EUR 2 mln
M impact | EQUITY | Oct 29, 2026, 09:20 AM UTC
Aztech Global Subsidiary Faces USD 19.4 Million Customer Claim
M impact | EQUITY | Oct 29, 2026, 09:19 AM UTC
Asian Paints Q2 Profit Misses Estimates as Costs Rise
Asian Paints reported a second-quarter profit rise that missed estimates, as rising expenses and intensifying competition weighed.
M impact | EQUITY | Oct 29, 2026, 09:18 AM UTC
Sanofi Consumer shares jump 11% after strong Q3 results
Sanofi Consumer Healthcare shares surged as much as 11% in Thursday trading after the company reported strong September-quarter FY27 results. Shares opened at Rs.3,502.20, versus t
M impact | EQUITY | Oct 29, 2026, 09:18 AM UTC